272 related articles for article (PubMed ID: 19047484)
21. Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling.
Costa MJ; Song Y; Macours P; Massart C; Many MC; Costagliola S; Dumont JE; Van Sande J; Vanvooren V
Endocrinology; 2004 Mar; 145(3):1464-72. PubMed ID: 14670987
[TBL] [Abstract][Full Text] [Related]
22. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
Karakoula A; Tovey SC; Brighton PJ; Willars GB
Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
[TBL] [Abstract][Full Text] [Related]
23. The guanine nucleotide exchange factor Vav2 is a negative regulator of parathyroid hormone receptor/Gq signaling.
Emami-Nemini A; Gohla A; Urlaub H; Lohse MJ; Klenk C
Mol Pharmacol; 2012 Aug; 82(2):217-25. PubMed ID: 22554804
[TBL] [Abstract][Full Text] [Related]
24. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1.
El Zein N; Badran B; Sariban E
J Leukoc Biol; 2008 Apr; 83(4):972-81. PubMed ID: 18174366
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M
Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976
[TBL] [Abstract][Full Text] [Related]
26. Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.
Conklin BR; Herzmark P; Ishida S; Voyno-Yasenetskaya TA; Sun Y; Farfel Z; Bourne HR
Mol Pharmacol; 1996 Oct; 50(4):885-90. PubMed ID: 8863834
[TBL] [Abstract][Full Text] [Related]
27. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication.
Schöneberg T; Sandig V; Wess J; Gudermann T; Schultz G
J Clin Invest; 1997 Sep; 100(6):1547-56. PubMed ID: 9294123
[TBL] [Abstract][Full Text] [Related]
28. Galphaq-coupled receptor signaling enhances adenylate cyclase type 6 activation.
Beazely MA; Watts VJ
Biochem Pharmacol; 2005 Jul; 70(1):113-20. PubMed ID: 15885660
[TBL] [Abstract][Full Text] [Related]
29. G protein coupling and signaling pathway activation by m1 muscarinic acetylcholine receptor orthosteric and allosteric agonists.
Thomas RL; Mistry R; Langmead CJ; Wood MD; Challiss RA
J Pharmacol Exp Ther; 2008 Nov; 327(2):365-74. PubMed ID: 18664591
[TBL] [Abstract][Full Text] [Related]
30. Phosphatidic acid regulates signal output by G protein coupled receptors through direct interaction with phospholipase C-beta(1).
Litosch I; Pujari R; Lee SJ
Cell Signal; 2009 Sep; 21(9):1379-84. PubMed ID: 19414067
[TBL] [Abstract][Full Text] [Related]
31. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
[TBL] [Abstract][Full Text] [Related]
32. Optical biosensor provides insights for bradykinin B(2) receptor signaling in A431 cells.
Fang Y; Li GG; Peng J
FEBS Lett; 2005 Nov; 579(28):6365-74. PubMed ID: 16263113
[TBL] [Abstract][Full Text] [Related]
33. CCR5 internalisation and signalling have different dependence on membrane lipid raft integrity.
Cardaba CM; Kerr JS; Mueller A
Cell Signal; 2008 Sep; 20(9):1687-94. PubMed ID: 18573334
[TBL] [Abstract][Full Text] [Related]
34. Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells.
Parker SL; Parker MS; Sah R; Balasubramaniam A; Sallee FR
Eur J Pharmacol; 2008 Jan; 579(1-3):13-25. PubMed ID: 17967449
[TBL] [Abstract][Full Text] [Related]
35. Agonist-induced tyrosine phosphorylation of Gq/G11 alpha requires the intact structure of membrane domains.
Matousek P; Durchánková D; Svandová I; Novotny J; Svoboda P
Biochem Biophys Res Commun; 2005 Mar; 328(2):526-32. PubMed ID: 15694379
[TBL] [Abstract][Full Text] [Related]
36. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
Beyermann M; Heinrich N; Fechner K; Furkert J; Zhang W; Kraetke O; Bienert M; Berger H
Br J Pharmacol; 2007 Jul; 151(6):851-9. PubMed ID: 17533422
[TBL] [Abstract][Full Text] [Related]
37. Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s).
Ostrom RS; Post SR; Insel PA
J Pharmacol Exp Ther; 2000 Aug; 294(2):407-12. PubMed ID: 10900212
[TBL] [Abstract][Full Text] [Related]
38. Charged residues of the conserved DRY triplet of the vasopressin V1a receptor provide molecular determinants for cell surface delivery and internalization.
Hawtin SR
Mol Pharmacol; 2005 Oct; 68(4):1172-82. PubMed ID: 16049168
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol content drives distinct pharmacological behaviours of micro-opioid receptor in different microdomains of the CHO plasma membrane.
Gaibelet G; Millot C; Lebrun C; Ravault S; Sauliere A; Andre A; Lagane B; Lopez A
Mol Membr Biol; 2008 Aug; 25(5):423-35. PubMed ID: 18651319
[TBL] [Abstract][Full Text] [Related]
40. Dominant portion of thyrotropin-releasing hormone receptor is excluded from lipid domains. Detergent-resistant and detergent-sensitive pools of TRH receptor and Gqalpha/G11alpha protein.
Rudajev V; Novotny J; Hejnova L; Milligan G; Svoboda P
J Biochem; 2005 Aug; 138(2):111-25. PubMed ID: 16091585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
